Jonathan Smith, Author at Labiotech.eu

About

Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.

Articles by Jonathan Smith

nanobiotix nanotechnology nanoparticle cancer

More News! 28 May 2019

Nanomedicine Company Launches in France to Improve Drug Safety

The French nanomedicine biotech Nanobiotix is spinning out a subsidiary company developing nanoparticles that can enhance a drug’s effectiveness and decrease side effects. Called Curadigm, the spinout will be developing nanotechnology with the potential to make low drug doses more effective at treating different conditions, which could make treatments cheaper and with fewer side effects […]

May 28, 2019 - 2 minutesmins - By Jonathan Smith

small respiratory syncytial virus alzheimers disease sweden 1

News and Trends 28 May 2019

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

Scientists in Sweden have found that some viruses can increase the buildup of protein ‘plaques’ linked to Alzheimer’s disease, a discovery that could lead to new vaccines treating the condition. According to Kariem Ezzat, one of the lead researchers based in Stockholm University, the group is looking for industrial collaborators to develop vaccines against viruses […]

May 28, 2019 - 3 minutesmins - By Jonathan Smith

More News! 24 May 2019

French Pharma Acquires Israeli Microalgae Biotech

The French pharmaceutical manufacturer Solabia has acquired the Israeli biotech Algatech, which grows microalgae to produce bio-sourced food additives. The financial details of the acquisition were undisclosed. The incoming financial backing from Solabia will fuel the expansion of Algatech’s manufacturing muscle and research programs, which are based in the deserts of Israel. The acquisition represents […]

May 24, 2019 - 2 minutesmins - By Jonathan Smith

Startup Scout 24 May 2019

This Biotech Uses Gene Editing to Count Chickens Before They Hatch

In the city of Jerusalem, eggXYt is developing gene edited chickens whose male chicks fluoresce inside the egg. This could prevent the suffering of billions of male chicks in the egg-production industry, which are currently culled after hatching. Mission: To develop a gene edited breed of chickens whose sex can be determined before hatching using […]

May 24, 2019 - 3 minutesmins - By Jonathan Smith

microbiome fecal transplant maat pharma enterobiotix

News and Trends 22 May 2019

Microbiome Companies Unite to Push for EU Regulation Reform

European microbiome biotechs have launched a collaboration to streamline the EU’s regulatory pathways for microbiome-based treatments, which have the potential to treat inflammatory disease and bacterial infection. The companies will propose EU regulatory changes that make it easier to commercialize treatments based on targeting a patient’s microbiome bacteria. Microbiome-based treatments form a young field in […]

May 22, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 21 May 2019

The Top 20 Women in Leading Biotech Roles in Europe

The biotech industry has often been criticized for its lack of gender diversity. While there is still a long way to go to achieve ideal levels of equality, there are more and more women filling leading roles in companies across Europe. Here are 20 women making an impact in the European biotech industry. Diversity comes […]

May 21, 2019 - 12 minutesmins - By Jonathan Smith

Startup Scout 17 May 2019

This Biotech Detects Fraudulent Food by Checking its DNA

Spun out of the University of Milano-Bicocca, the Italian biotech Fem2-Ambiente aids in the fight against food contamination and fraud by sequencing DNA traces from food samples. Mission: To use DNA barcoding to make sure that foods are free from contamination, such as fraudulent ingredients, microbes or allergenic particles. Food fraud is a crime where […]

May 17, 2019 - 3 minutesmins - By Jonathan Smith

More News! 16 May 2019

Israeli Startup Raises €11M to Become the First to Sell Lab-Grown Steaks

Aleph Farms has closed a Series A round of €10.7M ($12M) to beef up its manufacturing and get its lab-grown steaks into the market within the next four years. Aleph Farms is the first company to have created a lab-grown beef steak, which was publicly tasted last December. With the money raised, the company aims […]

May 16, 2019 - 2 minutesmins - By Jonathan Smith

dna synthesis synthetic biology cambridge

More News! 16 May 2019

UK Scientists Open Bacterial Genome Up to Making Artificial Proteins

A research group from the University of Cambridge has created bacteria with less complexity in their genome, which could free up DNA code for producing synthetic proteins never before seen in nature. There are lots of redundancies in the DNA code, meaning there is sometimes more than one DNA sequence that can result in the […]

May 16, 2019 - 2 minutesmins - By Jonathan Smith

mobidiag antibiotic resistance diagnostic

News and Trends 15 May 2019

€25M European Loan to Fund Diagnostics Tackling Antibiotic Resistance

The Finnish biotech Mobidiag has received a loan of €25M from the European Investment Bank to commercialize diagnostic technology aimed at reducing antibiotic resistance. When patients get a bacterial infection, clinicians have to wait several days for traditional diagnosis techniques to tell them what kind of bacteria is causing the infection. While they wait, the […]

May 15, 2019 - 2 minutesmins - By Jonathan Smith

celixir rnai silencing cancer colon breast

News and Trends 14 May 2019

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

Developed by the UK biotech Celixir, a therapy based on silencing genes with RNA molecules in a process called RNAi has shrunk tumors by 50% in culture. Although there are lots of innovative cancer treatments in the market, such as CAR T-cell therapy for blood cancer, solid tumors remain difficult to tackle. For this reason, […]

May 14, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 May 2019

First Potential Gene Therapy for Hemophilia B Restores Blood Clotting in Phase II

A gene therapy developed by the Dutch biotech uniQure increased the activity of a blood clotting protein enough to stop bleeds in patients with the blood disorder hemophilia B. Hemophilia B is a rare genetic condition in which patients have a mutation in the blood clotting protein factor IX (FIX), reducing its activity below 6% […]

May 14, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Jonathan Smith

About

Articles by Jonathan Smith

Nanomedicine Company Launches in France to Improve Drug Safety

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

French Pharma Acquires Israeli Microalgae Biotech

This Biotech Uses Gene Editing to Count Chickens Before They Hatch

Microbiome Companies Unite to Push for EU Regulation Reform

The Top 20 Women in Leading Biotech Roles in Europe

This Biotech Detects Fraudulent Food by Checking its DNA

Israeli Startup Raises €11M to Become the First to Sell Lab-Grown Steaks

UK Scientists Open Bacterial Genome Up to Making Artificial Proteins

€25M European Loan to Fund Diagnostics Tackling Antibiotic Resistance

RNAi Therapy Smashes Solid Tumors in Preclinical Tests

First Potential Gene Therapy for Hemophilia B Restores Blood Clotting in Phase II

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Jonathan Smith

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!